New BePharBel Manufacturing global patent for MMCR technology (for multi-layer microparticle controlled release) opens the way to the manufacturing of modified release syrups, which will help improve treatment compliance in population with swallowing impairments like paediatric or elderly population.

2 POC have been obtained to date on Esomeprazole (delayed release) and Pramipexole (sustained release), used most specifically for gastroesophageal reflux and Parkinson disease treatments.